triazolam has been researched along with Diseases, Occupational in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walsh, JK | 1 |
| Muehlbach, MJ | 1 |
| Schweitzer, PK | 1 |
| Bickel, WK | 1 |
| Higgins, ST | 1 |
| Hughes, JR | 1 |
1 trial available for triazolam and Diseases, Occupational
| Article | Year |
|---|---|
Acute administration of triazolam for the daytime sleep of rotating shift workers.
Topics: Adaptation, Physiological; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method | 1984 |
1 other study available for triazolam and Diseases, Occupational
| Article | Year |
|---|---|
Development of repeated acquisition methodologies: implications for the detection of drug-induced disruption in human learning.
Topics: Dose-Response Relationship, Drug; Humans; Illicit Drugs; Mental Recall; Neuropsychological Tests; Oc | 1990 |